• Quantum Biopharma filed an amended Form 6-K to update its earlier March 30, 2026 report.
• Amendment incorporated a previously issued March 30, 2026 press release into its Form F-3 registration statement.
• No other changes were made to the initial filing, beyond the incorporation-by-reference update.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-26-003864), on September 08, 2026, and is solely responsible for the information contained therein.